BioXcel Therapeutics Announces Executive Changes and Wind-Down Process

BioXcel Therapeutics announced on October 30, 2026, that it terminated four officers and appointed Samir Saleem as president and secretary. The leadership changes come amid a court-supervised bankruptcy sale and the planned wind-down of the company’s affairs. Its stock is trading under the ticker BTAIQ.